CN Stock MarketDetailed Quotes

Nanjing Pharmaceutical Group (600713)

Watchlist
  • 5.31
  • +0.01+0.19%
Noon Break May 8 11:29 CST
6.95BMarket Cap11.18P/E (TTM)

Nanjing Pharmaceutical Group (600713) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Wholesale51.89B94.41%
Retail sales2.61B4.74%
Electric quotient303.59M0.55%
Other business153.12M0.28%
Logistics service10.03M0.02%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Wholesale51.89B94.41%
Retail sales2.61B4.74%
Electric quotient303.59M0.55%
Other business153.12M0.28%
Logistics service10.03M0.02%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Jiangsu28.62B52.07%
Anhui16.06B29.21%
Hubei5.95B10.82%
Fujian3.9B7.10%
Other285.39M0.52%
Other business153.12M0.28%
Total special adjustments--
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More